FDA approves Roche's Herceptin for gastric cancer

10/20/2010 | Reuters

The FDA has approved the use of Roche Holding's Herceptin with chemotherapy for advanced HER2-positive stomach cancer. The approval was based on a pivotal study showing that the drug combination extended survival compared with chemotherapy alone.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC